Skip to main content
. 2024 Nov 12;16(1):43–71. doi: 10.1007/s13300-024-01660-0

Table 2.

Baseline HbA1c and weight by trial and subgroup

SURPASS-1
N = 478
SURPASS-2
N = 1878
SURPASS-3
N = 1437
SURPASS-4
N = 1995
SURPASS-5
N = 475
Duration of T2D
 ≤ 5 years 7.9% 8.1% 8.1% 8.4% 8.2%
87.1 kg 98.3 kg 97.8 kg 95.4 kg 105.3 kg
 > 5 to 10 years 7.9% 8.4% 8.2% 8.5% 8.3%
83.2 kg 94.5 kg 95.2 kg 92.2 kg 100.0 kg
 > 10 years 8.1% 8.4% 8.2% 8.6% 8.3%
83.5 kg 88.4 kg 89.6 kg 87.4 kg 91.5 kg
Baseline HbA1c
 ≤ 8.5% 7.6% 7.6% 7.7% 7.9% 7.8%
86.1 kg 94.4 kg 94.1 kg 90.0 kg 94.7 kg
 > 8.5% 9.3% 9.4% 9.3% 9.3% 9.2%
85.0 kg 92.5 kg 94.6 kg 90.6 kg 96.0 kg
Baseline BMI
 < 30 kg/m2 8.0% 8.4% 8.2% 8.5% 8.3%
72.1 kg 75.7 kg 77.5 kg 75.4 kg 74.6 kg
 30 to < 35 kg/m2 8.0% 8.3% 8.2% 8.6% 8.3%
87.6 kg 89.0 kg 91.8 kg 90.5 kg 94.6 kg
 ≥ 35 kg/m2 7.9% 8.2% 8.2% 8.5% 8.4%
107.8 kg 112.5 kg 112.3 kg 109.4 kg 113.2 kg
Baseline age
 < 65 years 8.0% 8.3% 8.2% 8.6% 8.4%
86.6 kg 95.9 kg 97.1 kg 93.9 kg 98.4 kg
 ≥ 65 years 7.8% 8.1% 8.1% 8.5% 8.1%
83.4 kg 86.9 kg 86.5 kg 86.2 kg 90.5 kg
Sex
 Female 7.9% 8.3% 8.2% 8.5% 8.3%
82.4 kg 87.6 kg 88.1 kg 83.6 kg 88.9 kg
 Male 8.0% 8.3% 8.1% 8.5% 8.3%
89.1 kg 100.6 kg 99.2 kg 94.3 kg 100.2 kg

Baseline HbA1c data are presented as %. Baseline weight data are presented in kg

BMI body mass index, HbA1c glycated hemoglobin, T2D type 2 diabetes